| |
|
|
|
|
|
|
|||
|
Blood, 7 May 2009, Vol. 113, No. 19, pp. 4575-4585. Prepublished online as a Blood First Edition Paper on February 9, 2009; DOI 10.1182/blood-2008-10-185223.
IMMUNOBIOLOGY The molecular signature of CD8+ T cells undergoing deletional tolerance1 Walter and Eliza Hall Institute of Medical Research, Parkville, Australia; 2 Department of Medical Biology, University of Melbourne, Parkville, Australia; 3 Immunobiology Department, Yale School of Medicine, New Haven, CT; 4 Division of Immunology and Genetics, John Curtin School of Medical Research, Australian National University, Acton, Australia; 5 School of Molecular and Microbial Biosciences, University of Sydney, Sydney, Australia; and 6 Department of Microbiology and Immunology, University of Melbourne, Parkville, Australia
Peripheral tolerance induction is critical for the maintenance of self-tolerance and can be mediated by immunoregulatory T cells or by direct induction of T-cell anergy or deletion. Although the molecular processes underlying anergy have been extensively studied, little is known about the molecular basis for peripheral T-cell deletion. Here, we determined the gene expression signature of peripheral CD8+ T cells undergoing deletional tolerance, relative to those undergoing immunogenic priming or lymphopenia-induced proliferation. From these data, we report the first detailed molecular signature of cells undergoing deletion. Consistent with defective cytolysis, these cells exhibited deficiencies in granzyme up-regulation. Furthermore, they showed antigen-driven Bcl-2 down-regulation and early up-regulation of the proapoptotic protein Bim, consistent with the requirement of this BH3-only protein for peripheral T-cell deletion. Bim up-regulation was paralleled by defective interleukin-7 receptor
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||